PTGS2 and Arthritis: However, treatment with celecoxib, a prototype drug belonging to a new generation of highly specific COX-2 inhibitors has been reported to have only mild suppressive effects on animal models of arthritis, and strong inhibition of arthritis was achieved only when mice were treated in the combination of celecoxib with leukotriene inhibitors [16-19].